Market Newsdesk

Advanced Energy Continues to Raise the Bar in Configurable Power Supplies With New CoolX^®3000

CoolX3000 provides highest performance, unique flexibility and intelligent control and monitoring for medical, life science and specialized industrial applications

DENVER–(BUSINESS WIRE)–Advanced Energy Industries, Inc. (Nasdaq: AEIS) – a global leader in highly engineered, precision power conversion, measurement and control solutions – today introduced its new Excelsys CoolX^®3000 modular, configurable power platform. Designed for a wide range of demanding medical and industrial applications, this 3000 W power supply platform delivers leading power density, provides unique flexibility, and features digital communication and control to connect with other applications to deliver on the promise of Industry 4.0.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201214005134/en/

Optimized for use in medical diagnostics, imaging and treatment equipment, life science systems, clinical chemistry as well as specialized industrial equipment, the CoolX3000 rounds out AE’s CoolX family of configurable power supplies, which includes the CX600, CX1000 and CX1800 Series.

CoolX3000 simplifies system integration for the world’s leading OEMs and provides unique levels of flexibility and scalability, with up to 24 isolated user field-configurable outputs and individual output controls. The CoolX3000 provides the highest power level in the range, offering full control of output voltage and current, as well as sequencing control via digital and analog interfaces. Further, CoolX3000 has full safety agency approval for operation in high altitude conditions of up to 5,000 meters, which is critical for medical applications.

“The CoolX3000 builds on Advanced Energy’s market-leading CoolX family of configurable power supplies and provides our medical, life science and industrial customers with a broader range of power, outputs and intelligent control capabilities to meet their design requirements,” said Conor Duffy, vice president and general manager, medical, at Advanced Energy. “For decades, customers have relied on AE’s line of highly reliable and extremely efficient power solutions. We are future-proofing our customers’ systems with the latest, advanced regulatory and safety approvals. With full digital communication and control, we are also a partner in enabling their Industry 4.0 initiatives.”

CoolX3000 meets the industry’s latest medical and industrial safety standards, including IEC60601-1 3rd edition, IEC60601-1-2 4th edition (EMC), IEC60950, IEC62368-1 and SEMI F47.

For detailed product information and technical specifications, visit the CoolX3000 product page.

About Advanced Energy

Advanced Energy (Nasdaq: AEIS) is a global leader in the design and manufacturing of highly engineered, precision power conversion, measurement and control solutions for mission-critical applications and processes. AE’s power solutions enable customer innovation in complex applications for a wide range of industries including semiconductor equipment, industrial, manufacturing, telecommunications, data center computing and healthcare. With engineering know-how and responsive service and support around the globe, the company builds collaborative partnerships to meet technology advances, propel growth for its customers and innovate the future of power. Advanced Energy has devoted more than three decades to perfecting power for its global customers and is headquartered in Denver, Colorado, USA. For more information, visit www.advancedenergy.com.

Advanced Energy | Precision. Power. Performance.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005134/en/

For press inquiries, contact:

Lora Wilson / Valerie Christopherson

Global Results Communications for Advanced Energy Industries, Inc.

[email protected]

+1 949.306.0276

KEYWORDS: Colorado United States North America

INDUSTRY KEYWORDS: Technology Manufacturing Other Health Health Semiconductor Other Energy Other Manufacturing Alternative Energy Energy Engineering Hardware

MEDIA:

Logo

Photo

Advanced Energy’s new Excelsys CoolX3000 modular, configurable power platform is designed for a wide range of demanding medical and industrial applications. This 3000 W power supply platform delivers leading power density, provides unique flexibility, and features digital communication and control to connect with other applications to deliver on the promise of Industry 4.0. (Photo: Business Wire)

Liberty Broadband and GCI Liberty Announce Receipt of Approvals from the Regulatory Commission of Alaska

ENGLEWOOD, Colo.–(BUSINESS WIRE)–
Liberty Broadband Corporation (“Liberty Broadband”) (NASDAQ: LBRDA, LBRDK) and GCI Liberty, Inc. (“GCI Liberty”) (NASDAQ: GLIBA, GLIBP) announced today that the Regulatory Commission of Alaska (“RCA”) has granted Liberty Broadband’s applications to acquire an indirect controlling interest in certain subsidiaries of GCI Liberty that hold certificates of public convenience and necessity issued by the RCA. As a result, Liberty Broadband and GCI Liberty have received all regulatory approvals required to complete the planned merger between the companies (“the Combination”). Liberty Broadband and GCI Liberty expect the Combination to close promptly following the receipt of required stockholder approvals.

About Liberty Broadband

Liberty Broadband Corporation’s (NASDAQ: LBRDA, LBRDK) businesses consist of its interest in Charter Communications and its subsidiary Skyhook.

About GCI Liberty, Inc.

GCI Liberty, Inc. (Nasdaq: GLIBA, GLIBP) operates and owns interests in a broad range of communications businesses. GCI Liberty’s assets consist of its subsidiary GCI Holdings, LLC (“GCI”) and interests in Charter Communications and Liberty Broadband. GCI is Alaska’s largest communications provider, providing data, wireless, video, voice and managed services to consumer and business customers throughout Alaska and nationwide. GCI has delivered services for nearly 40 years to some of the most remote communities and in some of the most challenging conditions in North America.

Forward-Looking Statements

This communication includes forward-looking statements. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws. These forward-looking statements generally can be identified by phrases such as “expects” or other words or phrases of similar import or future or conditional verbs such as “will,” “may,” “might,” “should,” “would,” “could,” or similar variations. Similarly, statements about the Combination, including satisfaction of conditions to the Combination and the timing of the Combination and other statements that are not historical facts are also forward-looking statements. It is uncertain whether any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do, what impact they will have on the results of operations and financial condition of the combined companies or the price of Liberty Broadband or GCI Liberty stock. These forward-looking statements involve certain risks and uncertainties, many of which are beyond the parties’ control, that could cause actual results to differ materially from those indicated in such forward-looking statements, including, but not limited to, the ability of the parties to consummate the Combination on a timely basis or at all and the satisfaction of the conditions precedent to consummation of the Combination, including, but not limited to, approval by the stockholders of Liberty Broadband and GCI Liberty. These forward-looking statements speak only as of the date of this communication, and Liberty Broadband expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statement contained herein to reflect any change in Liberty Broadband’s or GCI Liberty’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. Please refer to the publicly filed documents of Liberty Broadband and GCI Liberty, including the most recent Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, for additional information about Liberty Broadband and GCI Liberty and about the risks and uncertainties related to the businesses of Liberty Broadband and GCI Liberty which may affect the statements made in this communication.

Additional Information

Nothing in this communication shall constitute a solicitation to buy or an offer to sell any securities of Liberty Broadband or GCI Liberty, nor shall it constitute an offer, solicitation, or any sale in any jurisdiction in which such offer, solicitation, or sale is unlawful. The offer and sale of shares in the Combination will only be made pursuant to Liberty Broadband’s effective registration statement. Liberty Broadband’s stockholders, GCI Liberty’s stockholders and other investors are urged to read the joint proxy statement/prospectus included in the registration statement on Form S-4 filed regarding the Combination and any other relevant documents filed with the SEC, as well as any amendments or supplements to those documents, because they will contain important information about the Combination. Copies of these SEC filings are available free of charge at the SEC’s website (http://www.sec.gov). Copies of the filings together with the materials incorporated by reference therein are also available, without charge, by directing a request to Liberty Broadband, 12300 Liberty Boulevard, Englewood, Colorado 80112, Attention: Investor Relations, Telephone: (720) 875-5700 or to GCI Liberty, Inc., 12300 Liberty Boulevard, Englewood, Colorado 80112, Attention: Investor Relations, Telephone: (720) 875-5900.

Participants in the Solicitation

Liberty Broadband and GCI Liberty and their respective directors and executive officers and other persons may be deemed to be participants in the solicitation of proxies in respect of the Combination. Information about Liberty Broadband’s directors and executive officers is available in Liberty Broadband’s definitive proxy statement for its 2020 annual meeting of stockholders, which was filed with the SEC on April 10, 2020. Information about GCI Liberty’s directors and executive officers is available in GCI Liberty’s definitive proxy statement for its 2020 annual meeting of stockholders, which was filed with the SEC on April 10, 2020. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, are contained in the joint proxy statement/prospectus included in the registration statement on Form S-4 filed with the SEC and other relevant materials to be filed with the SEC, as well as any amendments or supplements to those documents, regarding the Combination when they become available. Investors should read the joint proxy statement/prospectus included in the registration statement on Form S-4 carefully before making any voting or investment decisions. You may obtain free copies of these documents from Liberty Broadband and GCI Liberty as indicated above.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005162/en/

Liberty Broadband Corporation

Courtnee Chun, 720-875-5420

GCI Liberty, Inc.

Courtnee Chun, 720-875-5420

KEYWORDS: Alaska Colorado United States North America

INDUSTRY KEYWORDS: Technology Communications Other Communications Telecommunications

MEDIA:

Logo

AtriCure to Participate in the 39^th Annual J.P. Morgan Healthcare Conference

MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming 39^th Annual J.P. Morgan Healthcare Conference being held virtually.

AtriCure’s management is scheduled to present on Monday, January 11, 2021, at 10:00 a.m. Eastern Time. Interested parties may access a live audio webcast of the presentation by visiting the “Investors” section of the company’s website at https://ir.atricure.com.

AtriCure’s management is also scheduled to participate in one-on-one investor meetings in a virtual setting at the Needham Annual Growth Conference on Thursday, January 14, 2021. Due to the format of this event, no webcast will be available.

About AtriCure

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator^® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip^® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005105/en/

Angie Wirick

AtriCure, Inc.

Chief Financial Officer

(513) 755-5334

[email protected]

Lynn Pieper Lewis

Gilmartin Group

Investor Relations

(415) 937-5402

[email protected]

KEYWORDS: United States North America Ohio

INDUSTRY KEYWORDS: Surgery Medical Devices Hospitals Health Cardiology

MEDIA:

Logo

Avaya Earns Frost & Sullivan Award for Excellence in Healthcare Solutions

Competitive Strategy Leadership Award Recognizes Avaya’s Extensive Portfolio and Overall Ability to Improve Patient Care and Engagement

RALEIGH-DURHAM, N.C.–(BUSINESS WIRE)–Avaya (NYSE: AVYA), a global leader in solutions to enhance and simplify communications and collaboration, today announced it has earned Frost & Sullivan’s Competitive Strategy Leadership Award for its extensive portfolio of Avaya OneCloud healthcare solutions.

The firm recognized Avaya based on its healthcare-specific portfolio of solutions capable of being adapted to a wide range of healthcare use cases, along with its ability to assess and respond to the industry’s particular requirements. The company’s global footprint, strong brand and track record, and possession of the necessary know-how to quickly adapt to a rapidly-changing environment placed Avaya in a position that very few other organizations can claim.

“We are proud of the role our healthcare solutions play in enhancing the experience for patients, families, care teams and all others that touch the patient journey. Avaya enables healthcare organizations to engage across the care continuum delivering experiences that matter when they truly matter most,” said Tara Mahoney, Global Healthcare Practice Leader, Avaya. “Many of our healthcare customers are pursuing digital transformation to adapt as health systems are faced with unprecedented pressure to support patients under extreme resource constraints, especially during the pandemic. By connecting people, resources, data, and more, Avaya is helping customers optimize their operations and reduce risk while strengthening the level of care they can provide to patients and customers. We are very pleased to receive this recognition from Frost & Sullivan and will continue to drive innovation and positive outcomes for our healthcare clients.”

Healthcare providers across all facets of the industry are a priority for Avaya, and the company works with 80 percent of the Health and Life Sciences Fortune 500 Companies, and 12 of the top 20 U.S. hospitals rely on Avaya OneCloud communications solutions, including Avaya Spaces and Avaya OneCloud CPaaS. Avaya solutions for Healthcare include:

Care Team Collaboration

• Improve care coordination with mobile collaboration across the entire health system
• Increase time with patients by enabling the care team to engage with the right resource by name, patient assignment or role
• Ensure collaboration is integrated into clinical workflows and applications for improved patient quality and experience

Patient Access & Services

• Improve the patient experience with a rich multi-touchpoint solution driving improved access, revenue cycle and care plan adherence.
• Reduce no-shows and leakage and improve pre- and post-procedure instructions by leveraging automation, proactive engagement and digital deflection in communicating with patients.
• Allow patient representatives to focus on the most critical patient inquiries through automation and digital deflection of more routine inquiries and communications.
• Leverage integrations with EHR, business applications, customer portals for contextual communications with patients and members.

Virtual Care

• Reduce avoidable emergent and urgent care and better manage population health through telehealth triage.
• Improve quality metrics and staff efficiencies with remote monitoring, bedside consult and virtual rounding on industry-leading video devices and cloud collaboration.
• Deliver provider, patient and scheduler tools and workflows truly needed for one-click virtual visits for physician and mental wellness.
• Improve home and end-of-life care with immersive collaboration with the patient, family and entire care team in the home and remotely.

“Avaya stands out among communications and collaboration providers with its ability to address a broad spectrum of customer needs and requirements within the healthcare vertical industry,” said Elka Popova, VP, Information & Communications Technologies, Frost & Sullivan. “From on-premise and cloud-based communications, collaboration and customer experience solutions, to a wide range of devices, professional services and programmable capabilities, Avaya brings a comprehensive portfolio to help optimize important workflows within healthcare organizations. As the healthcare vertical prepares for the era of digital sustainability, Avaya is well positioned to become the partner of choice for healthcare providers at any stage of their digital transformation journey.”

Avaya recently earned the 2020 Pandemic Tech Innovation Award for Exceptional Innovation, recognizing its solutions for helping society and business function effectively in the face of challenges caused by the global COVID-19 pandemic. Additionally, TrustRadius selected Avaya for the 2020 Tech Cares Award for going above and beyond to provide global communities, clients, and frontline workers with support during the COVID-19 crisis.

Further information about Frost & Sullivan’s Research Methodology can be found here.

Additional Resources

• Find more information about Avaya’s healthcare solutions
• Learn more about Delivering Excellent Communications and Collaboration Experiences in Healthcare
• Read the full report from Frost & Sullivan
• Learn how to solve today and tomorrow’s healthcare communication challenges
• Read our blog, Experts Share How to Create an Effective Contact Tracing Program
• The Crisis Within a Crisis: How to Steer Your Health Systems’ Communications During and After COVID-19, learn more
• Check out a recent blog on Becker’s Health IT, The consumer-driven technology that could be the cure to healthcare’s patient access problem

About Avaya

Businesses are built by the experiences they provide, and everyday millions of those experiences are delivered by Avaya Holdings Corp. (NYSE: AVYA). Avaya is shaping what’s next for the future of work, with innovation and partnerships that deliver game-changing business benefits. Our cloud communications solutions and multi-cloud application ecosystem power personalized, intelligent, and effortless customer and employee experiences to help achieve strategic ambitions and desired outcomes. Together, we are committed to help grow your business by delivering Experiences that Matter. Learn more at http://www.avaya.com.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector, and the investment community.

Cautionary Note Regarding Forward-Looking Statements

This document contains certain “forward-looking statements.” All statements other than statements of historical fact are “forward-looking” statements for purposes of the U.S. federal and state securities laws. These statements may be identified by the use of forward looking terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “our vision,” “plan,” “potential,” “preliminary,” “predict,” “should,” “will,” or “would” or the negative thereof or other variations thereof or comparable terminology. The Company has based these forward-looking statements on its current expectations, assumptions, estimates and projections. While the Company believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond its control. The factors are discussed in the Company’s Annual Report on Form 10-K and subsequent quarterly reports on Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) available at www.sec.gov, and may cause the Company’s actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. The Company cautions you that the list of important factors included in the Company’s SEC filings may not contain all of the material factors that are important to you. In addition, in light of these risks and uncertainties, the matters referred to in the forward-looking statements contained in this press release may not in fact occur. The Company undertakes no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Source: Avaya Newsroom

View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005136/en/

For Media Inquiries:

Alex Alias

[email protected]

 

KEYWORDS: North Carolina United States North America

INDUSTRY KEYWORDS: Data Management Technology VoIP Telecommunications Software Internet

MEDIA:

Logo

Wabtec Declares Regular Quarterly Common Dividend

PITTSBURGH–(BUSINESS WIRE)–
Wabtec Corporation (NYSE: WAB) announced today that its Board of Directors declared a regular quarterly common dividend of 12 cents per share, payable on February 26, 2021 to holders of record on February 12, 2021.

About Wabtec Corporation

Wabtec Corporation is a leading global provider of equipment, systems, digital solutions and value-added services for freight and transit rail. Drawing on nearly four centuries of collective experience across Wabtec, GE Transportation and Faiveley Transport, the company has unmatched digital expertise, technological innovation, and world-class manufacturing and services, enabling the digital-rail-and-transit ecosystems. Wabtec is focused on performance that drives progress, creating transportation solutions that move and improve the world. The freight portfolio features a comprehensive line of locomotives, software applications and a broad selection of mission-critical controls systems, including Positive Train Control (PTC). The transit portfolio provides highly engineered systems and services to virtually every major rail transit system around the world, supplying an integrated series of components for buses and all train-related market segments that deliver safety, efficiency and passenger comfort. Along with its industry-leading portfolio of products and solutions for the rail and transit industries, Wabtec is a leader in mining, marine and industrial solutions. Visit: www.WabtecCorp.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005027/en/

Wabtec Investor Contact

Kristine Kubacki, CFA / [email protected] / 412-450-2033

Wabtec Media Contact

Deia Campanelli / [email protected] / 773-297-0482

KEYWORDS: Pennsylvania United States North America

INDUSTRY KEYWORDS: Rail Technology Transport Logistics/Supply Chain Management Software Hardware

MEDIA:

Posted on December 14, 2020 8:03 am

Strong Retail Sales Performance and Sell Through Result In Regional Grocer Save Mart To Expand cbdMD and Paw CBD Brand Offerings To Additional 100 Locations

Strong Retail Sales Performance and Sell Through Result In Regional Grocer Save Mart To Expand cbdMD and Paw CBD Brand Offerings To Additional 100 Locations

CHARLOTTE, N.C.–(BUSINESS WIRE)–
cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) announced that regional grocer Save Mart has agreed to expand their cbdMD product offerings to additional locations due to strong retail sales performance and sell through of cbdMD and Paw CBD brands.

The Save Mart Companies, a regional grocer which owns and operates stores under the banners of Save Mart, Lucky, Lucky California and FoodMaxx throughout California and Northern Nevada, has expanded their cbdMD and Paw CBD product offerings into 100 additional locations, from the initial five locations.

“Retailers across America are finding that our cbdMD and Paw CBD brands are achieving excellent sell through results and therefore they are expanding our product offerings across their distribution channels,” said Pancho Mangual, EVP of Sales at cbdMD, Inc.

About cbdMD, Inc.

cbdMD, Inc. is a nationally recognized consumer cannabidiol (CBD) brand whose current products include CBD tinctures, CBD capsules, CBD gummies, CBD topicals, CBD bath bombs, and CBD pet products. cbdMD is also a proud partner of Bellator MMA and Life Time, Inc., and has one of the largest rosters of professional sports athletes who are part of “Team cbdMD.” To learn more about cbdMD and our comprehensive line of over 100 SKUs of U.S. produced, non-THC¹ CBD products, please visit www.cbdMD.com, follow cbdMD on Instagram and Facebook, or visit one of the 6,000 retail outlets that carry cbdMD products.

About The Save Mart Companies

The Save Mart Companies operate 206 stores throughout California and Northern Nevada under the banners of FoodMaxx, Lucky, Lucky California and Save Mart. Based in the Central Valley, TSMC is committed to sourcing a wide variety of local products to communities throughout California and Northern Nevada. In addition to its retail operation, the company also operates Smart Refrigerated Transport and is a partner in Super Store Industries (SSI), which owns and operates a distribution center in Lathrop and the Sunnyside Farms dairy processing plant in Turlock. For more information on the company, please visit: www.TheSaveMartCompanies.com.

Forward-Looking Statements

This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ”should,” ”may,” ”intends,” ”anticipates,” ”believes,” ”estimates,” ”projects,” ”forecasts,” ”expects,” ”plans,” and ”proposes.” These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including, without limitation, statements made with respect to the expansion of the consumer market for CBD products and our ability to increase our market share, challenges related to the impact of the COVID-19 environment, our limited operating history, our ability to expand our business and significantly increase our net sales, our ability to effectively leverage our brand partnerships and sponsorships, our ability to effectively compete in our market, and our ability to report profitable operations in the future. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” in cbdMD, Inc.’s Annual Report on Form 10-K for the fiscal year ended September 30, 2019, as amended, and our Quarterly Report on Form 10-Q for the period ended June 30, 2020, both as filed with the Securities and Exchange Commission (the “SEC”) and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.

______________________________

¹ Non-THC is defined as below the level of detection using validated scientific analytical tools.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005023/en/

John Weston

Director of Investor Relations

[email protected]

704-249-9515

KEYWORDS: North Carolina United States North America

INDUSTRY KEYWORDS: Other Consumer Other Retail Supermarket Specialty Alternative Medicine Health Consumer Retail Online Retail

MEDIA:

Logo

National Tree Company Revamps Order Processing with Hewlett Packard Enterprise Just in Time for the Holidays

HPE Nimble Storage dHCI delivers 70 percent better efficiency when managing orders for National Tree Company

SAN JOSE, Calif.–(BUSINESS WIRE)–
Hewlett Packard Enterprise (HPE) today announced that the National Tree Company, a large manufacturer of artificial holiday décor, has restructured their IT infrastructure with HPE Nimble Storage dHCI for better performance when processing customer orders. National Tree Company joins a growing number of companies that have selected HPE Nimble Storage dHCI to deliver breakthrough simplicity and efficiency. In Q4 earnings results, HPE announced that HPE Nimble Storage dHCI grew revenues by 280% year-over-year.

National Tree Company is a leading importer and wholesaler of artificial holiday and outdoor decorations. With the recent introduction of an expanded product line to include year-round seasonal decorations, the family owned company was in need of a major IT infrastructure overhaul in order to keep up with customer demand. Previously a brick and mortar business, National Tree Company has been moving to an online model as part of their digital transformation initiative, lending to a high demand for a virtual desktop infrastructure, and a system that could support the company’s growth.

HPE Nimble Storage dHCI and partner PKA Technology helped National Tree Company on its digital transformation journey, moving from mostly manual business operations, to interconnecting their warehouses and speeding up their entire printing and shipping process. With HPE Nimble Storage dHCI, National Tree Company is now able to print and process orders as needed, in as little as 20 minutes, compared to overnight, leading to a 70 percent increase in production, and eliminating backorders. This has drastically improved the entire workflow for warehouse processing and order printing, allowing National Tree Company to get shipments out the door and to their customers faster.

“The words ‘busy season’ will become obsolete for us as faster order processing allows us to operate and make decisions for the business more quickly,” said Jason Grenard, Director of IT, National Tree Company. “A quicker system has changed the way we live and work by making disruptions and complex infrastructure management a thing of the past, allowing us to sleep better, think, and focus on the business.”

The previous IBM systems National Tree Company was running restricted them to processing customer orders at a cap. Since implementing HPE Nimble Storage dHCI, a disaggregated hyperconverged infrastructure platform that overcomes the limitations of traditional infrastructure with intelligent management, easier scalability, and cloud data protection, National Tree Company software developers removed the cap, and are processing orders as they come in.

“HPE has always come through at every organization I have worked at,” said Grenard. “The marriage of HPE servers and Nimble Storage with HPE InfoSight is perfect. It gives me a holistic view of everything that we needed to see to continue building our data center.”

Utilizing HPE InfoSight, the industry’s most advanced AI for infrastructure, enables National Tree Company to gain insights into virtual machine performance, how servers are performing on any given day, and capacity utilization. HPE StoreOnce is also being implemented for secure backups and data protection.

“HPE Nimble Storage dHCI is faster and a better price point than what we were paying before,” said Grenard. “And, I have the security that my environment is working the way it should with HPE InfoSight.”

HPE Nimble Storage dHCI is a category-defining platform powered with artificial intelligence. HPE Nimble Storage dHCI is designed from the ground up to deliver the HCI experience, but with more flexibility and better resiliency and performance than traditional HCI. Organizations like PetSure and Central Pacific Bank are choosing HPE Nimble Storage dHCI over competitive HCI platforms for business-critical apps and mixed-workloads due to the better performance, resiliency, efficiency and total cost of ownership.

About Hewlett Packard Enterprise

Hewlett Packard Enterprise is the global edge-to-cloud platform-as-a-service company that helps organizations accelerate outcomes by unlocking value from all of their data, everywhere. Built on decades of reimagining the future and innovating to advance the way we live and work, HPE delivers unique, open and intelligent technology solutions, with a consistent experience across all clouds and edges, to help customers develop new business models, engage in new ways, and increase operational performance. For more information, visit: www.hpe.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005022/en/

Editorial contact

Natassia Culp, Communications Manager, HPE

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Hardware Home Goods Retail Construction & Property Data Management Online Technology Supply Chain Management Online Retail Other Retail Specialty Software Interior Design Entertainment Internet

MEDIA:

Posted on December 14, 2020 8:03 am

Schibsted Doubles Digital Subscription Revenue on the Zuora Platform

Schibsted Doubles Digital Subscription Revenue on the Zuora Platform

 Decision by Scandinavian media giant to consolidate and migrate multiple entities to the Zuora platform pays off as digital subscription revenue hits the 1 billion NOK mark in 2020

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Zuora, Inc., (NYSE:ZUO) the leading cloud-based subscription management platform provider, announced today that its customer Schibsted ASA (OSE:SCHA) has doubled digital subscription revenue to 1 billion Norwegian krone (NOK) from 2018 to 2020. In 2017, Schibsted, a Norway-based multimedia group that owns and operates newspapers, online classified advertisement websites, publishing houses, and other multimedia services, began migrating its brands to the Zuora® platform.

With newspaper ad revenue continuing its long decline, media companies are increasingly relying on subscription models to stay afloat. Schibsted, with a global reputation as a forward-thinking media company, has led the way, making digital subscriptions central to its business strategy. News-hungry consumers have responded, subscribing to Schibsted’s newspapers (with digital leading print) in ever greater numbers.

The challenge for Schibsted has been operational: how to maximize synergies across their large family of brands. Schibsted companies currently use four different platforms to manage their subscriptions. Each company manages payments, dunning, customer service, and marketing automation independently. This siloed approach is inefficient and makes it difficult to cross-sell across brands.

“With multiple platforms, we don’t have the control we need,” explains Fredrik Schjold, Head of Consumer Business Technology at Schibsted. “We need one unified platform that is flexible and scalable—and digitally native.”

Schibsted chose Zuora as that single platform to consolidate onto because it’s flexible and can work across brands, providing consistency while also allowing for differences in pricing and packaging. This customizability is crucial not only for the various newspaper types (daily, tabloid, business, etc.) but also for non-news services, like online marketplaces and consumer sites such as Vektklubb, Norway’s largest weight loss service.

Perhaps the most important benefit Schibsted finds in Zuora is how it functions as a single source of truth for customer data. Data from all brands is exported into Schibsted’s data warehouse and mined for insights to help them predict and lower churn and improve customer communications.

As of September 2020, Schibsted had migrated 494,586 active subscribers to the Zuora platform, a year-over-year increase from 2019 of 582%. As a result, digital subscription revenue grew from 500 million NOK to 1 billion NOK from 2018 to 2020.

“We needed three main building blocks: billing subscription management, customer service, and market automation,” says Carl Friberg, Product Manager of Subscriptions at Schibsted. “Zuora helped us achieve that and helped us deploy growth initiatives across brands.”

Read more about Schibsted in the case study here.

About Zuora, Inc.

Zuora provides the leading cloud-based subscription management platform that functions as a system of record for subscription businesses across all industries. Powering the Subscription Economy®, the Zuora platform was architected specifically for dynamic, recurring subscription business models and acts as an intelligent subscription management hub that automates and orchestrates the entire subscription order-to-revenue process seamlessly across billing and revenue recognition. Zuora serves more than 1,000 companies around the world, including Box, Ford, Penske Media Corporation, Schneider Electric, Siemens, Xplornet, and Zoom. Headquartered in Silicon Valley, Zuora also operates offices around the world in the U.S., EMEA and APAC. To learn more about the Zuora platform, please visit www.zuora.com.

© 2020 Zuora, Inc. All Rights Reserved. Zuora, Subscribed, Subscription Economy, Powering the Subscription Economy, and Subscription Economy Index are trademarks or registered trademarks of Zuora, Inc. Third party trademarks mentioned above are owned by their respective companies. Nothing in this press release should be construed to the contrary, or as an approval, endorsement or sponsorship by any third parties of Zuora, Inc. or any aspect of this press release.

SOURCE: Zuora Financial

View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005179/en/

Jayne Gonzalez

[email protected]

408-348-1087

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Software Technology Internet Data Management

MEDIA:

Logo

Legend Biotech Announces FDA Clearance of the IND for LB1901, an Investigational Autologous Anti-CD4 CAR-T Therapy for Relapsed or Refractory T-Cell Lymphoma

SOMERSET, N.J.–(BUSINESS WIRE)–
Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to evaluate LB1901, the company’s investigational autologous chimeric antigen receptor T-cell (CAR-T) therapy, for the treatment of adults with relapsed or refractory T-cell lymphoma (TCL). Under this IND, Legend will initiate a Phase 1 clinical study for LB1901 in the United States.

LB1901 is an investigational CAR-T product targeting CD4, which is a surface membrane glycoprotein uniformly expressed in a majority of TCL subtypes. A Phase 1, first-in-human, open-label, multicenter, multicohort clinical study will enroll patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) or cutaneous T-cell lymphoma (CTCL) in the United States. The primary objectives of the study are to characterize the safety and tolerability of LB1901 and to determine the recommended Phase 2 dose.

TCL is a heterogeneous group of disorders accounting for less than 15 percent of Non-Hodgkin lymphoma cases in the US.^1,2 PTCL comprises subtypes which are uncommon and often aggressive, with a 5-year overall survival of 39% that varies by subtype.^3,4 Cutaneous T-cell lymphomas are a group of T-cell malignancies, which occur primarily in the skin.⁵ Despite current treatment options, a substantial proportion of patients with PTCL or CTCL experiences relapse. A high unmet medical need remains for patients with relapsed or refractory PTCL and CTCL.

“The FDA’s clearance of Legend’s IND application for LB1901 is a milestone representative of the company’s scientific expertise in cell therapy innovation,” said Ying Huang, PhD, Chief Executive Officer and Chief Financial Officer of Legend Biotech. “We look forward to working with the investigators as we explore its potential in meeting the great unmet medical needs in the TCL population.”

About Legend Biotech

Legend Biotech is a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications. Our team of more than 800 employees across the United States, China and Europe, along with our differentiated technology, global development, and manufacturing strategies and expertise, provide us with the strong potential to discover, develop, and manufacture cutting edge cell therapies for patients in need.

Cautions Concerning Forward-Looking Statements

This information constitutes forward-looking statements relating to the business of Legend, including express or implied discussions regarding the clinical development of its product candidates and potential attributes and benefits of such product candidates. Such forward-looking statements reflect the current views of Legend’s management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, Legend’s expectations could be affected by, among other things, uncertainties involved in the development of new pharmaceutical products; unexpected clinical trial results, including additional analysis of existing clinical data or unexpected new clinical data; unexpected regulatory actions or delays or government regulation generally; Legend’s ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry, and general public pricing and other political pressures. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated or expected.

The safety and efficacy of the product candidates and/or uses under investigation have not been established. There is no guarantee that the product candidates will receive health authority approval or become commercially available in any country for the uses being investigated.

The information in this press release speaks only as of the date hereof. Legend assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon the information on this page as current or accurate after its publication date.

________________________________

¹ Scherer LD, Brenner MK, Mamonkln M. Chimeric antigen receptors for T-cell malignancies. Frontiers in Oncology. 2019 March;9(article 126):1-10.

² American Cancer Society. Types of T-cell Lymphoma. Available at: https://www.cancer.org/cancer/non-hodgkin-lymphoma/about/t-cell-lymphoma.html. Accessed December 2020.

³ Casulo C, O’Connor O, Shustov A, Fanale M, Friedberg JW, Leonard JP, et al. T-cell lymphoma: Recent advances in characterization and new opportunities for treatment. J Natl Cancer Inst. 2017;109(2):1-9.

⁴ Abouyabis AN, Shenoy PJ, Sinha R, Flowers CR, Lechowicz MJ. A systematic review and meta-analysis of front-line anthracycline based chemotherapy regimens for peripheral T-cell lymphoma. ISRN Hematol. 2011;2011:623924.

⁵ Scarfo I, Frigault M, Maus M. CAR-based approaches to cutaneous T-cell lymphoma. Frontiers in Oncology. 2019;9(article 259):1-6.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005067/en/

For Media and Investor Relations inquiries, please contact:

Jessie Yeung, Head of Corporate Finance and Investor Relations, Legend Biotech

[email protected] or [email protected]

Surabhi Verma, Manager of Investor Relations and Corporate Communications, Legend Biotech

[email protected] or [email protected]

For Medical Affairs inquiries, please contact:

Tonia Nesheiwat, Executive Director, Medical Affairs, Legend Biotech

[email protected] or [email protected]

KEYWORDS: New Jersey United States North America

INDUSTRY KEYWORDS: Oncology FDA Health Clinical Trials Pharmaceutical Biotechnology

MEDIA:

Posted on December 14, 2020 8:03 am

Forward Air Corporation Announces Expansion Into California’s Inland Empire

Forward Air Corporation Announces Expansion Into California’s Inland Empire

GREENEVILLE, Tenn.–(BUSINESS WIRE)–
Forward Air Corporation (NASDAQ: FWRD) (the “Company” or “Forward”) is executing a growth strategy that involves organic infrastructure investments such as its ongoing less-than-truckload (LTL) network expansion, as well as inorganic investments, including acquisitions of complementary businesses. Today, Forward announced that it will bring its expedited LTL service to California’s Inland Empire region.

Forward’s new facility in Fontana, CA will support the entire Inland Empire region. The Fontana facility is Forward’s fifth location in California, and second facility in greater Los Angeles – an area in which the Company has experienced strong growth. In addition to bringing best-in-class transportation times to the Inland Empire, the new facility is expected to create operational efficiencies with Forward’s Los Angeles terminal.

Tom Schmitt, Chairman, President and Chief Executive Officer said, “The Inland Empire region plays a strategic role in our expansion plans. While we can support some of our largest customers here, we are also able to link smaller businesses to our portfolio of service offerings. We are growing our footprint in Southern California and supporting our existing operations at the same time.”

The new facility in Fontana marks Forward’s continued expansion of services beyond its traditional airport-to-airport footprint. With the introduction of expedited LTL service out of Fontana, the Inland Empire region is now connected to Forward’s nationwide network and portfolio of premium freight management services in LTL, full truckload, intermodal drayage and final mile delivery.

About Forward Air Corporation

Forward Air Corporation (NASDAQ: FWRD) is a leading asset-light freight and logistics company. We provide LTL, final mile, truckload, intermodal drayage and pool distribution services across the United States and in Canada. Headquartered in Greeneville, Tennessee, Forward operates approximately 200 facilities across the country and employs more than 5,200 people nationwide. We are more than a transportation company. As a single resource for your shipping needs, Forward is your supply chain partner. For more information, visit our website at www.forwardaircorp.com.

This press release may contain statements that might be considered as forward-looking statements or predictions of future operations including with respect to the expected creation of operational efficiencies with the Company’s Los Angeles terminal and the growth and future expansion of the Company’s network and footprint. Such statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and are based on management’s belief or interpretation of information currently available. These statements and assumptions involve certain risks and uncertainties including that the performance of the LTL service in Inland Empire is worse than anticipated and that the Company is not able to achieve its planned expansion. Actual events may also differ from these expectations as a result of the risks identified from time to time in our filings with the Securities and Exchange Commission. You should consider the forward-looking statement contained herein in light of such risks. We assume no duty to update these statements as of any future date.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005031/en/

For media inquiries, please contact Justin Moss at [email protected] or 404-362-2472.

KEYWORDS: United States North America California Tennessee

INDUSTRY KEYWORDS: Trucking Rail Air Transport Logistics/Supply Chain Management Other Transport

MEDIA:

Logo